← Leaderboards
Linden T Hu
Tufts Medical Center
$37,353,232
Attributed
$44,166,702
Total exposure
28
Grants
25
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $7.2M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$51,706,301 · 29
By mechanism
R01$22,133,243 · 10
P01$9,745,597 · 4
C06$5,147,109 · 1
U01$4,930,203 · 2
R21$3,338,484 · 7
R42$3,000,000 · 1
Top collaborators
- Kim Lewis11 shared
- Margaret J Duncan5 shared
- Jonathan T Skare5 shared
- Tao Lin4 shared
- Linda K Bockenstedt1 shared
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionLyme DiseaseOrganismBorrelia BurgdorferiBacteriaAnimalsTicksPathogenGenesImmune ResponseLaboratoriesPathogenesisCollaborationsIn VitroExposure ToAntibiotic TherapySymptomsMutantCellsResponseAreaImmune SystemImmuneLead
Grant awards (92)
A Prospective Study of Persistent Symptoms of Lyme Disease$4,520,306
P01 · FY2025 · AI · contact PI
Immunology of Post-Treatment Lyme Disease Syndrome$1,013,656
P01 · FY2025 · AI · contact PI
Auto-antibodies as predictive markers for Post treatment Lyme Disease Syndrome$658,436
R01 · FY2025 · AI · contact PI
Microbiology of Post-Treatment Lyme Disease Syndrome$495,862
P01 · FY2025 · AI · contact PI
Development and Field Testing of a Novel Reservoir Targeted Antibiotic Against Borrelia burgdorferi$397,721
R01 · FY2025 · AI · contact PI
Administrative Core$120,304
P01 · FY2025 · AI · contact PI
A Prospective Study of Persistent Symptoms of Lyme Disease$3,019,293
P01 · FY2024 · AI · contact PI
Auto-antibodies as predictive markers for Post treatment Lyme Disease Syndrome$616,612
R01 · FY2024 · AI · contact PI
Role of human innate immune mutations in loss of tolerance to Borrelia burgdorferi$580,877
R01 · FY2024 · AI · contact PI
Immunology of Post-Treatment Lyme Disease Syndrome$413,308
P01 · FY2024 · AI · contact PI
Development and Field Testing of a Novel Reservoir Targeted Antibiotic Against Borrelia burgdorferi$348,435
R01 · FY2024 · AI · contact PI
Administrative Core$162,868
P01 · FY2024 · AI · contact PI
Development and Field Testing of a Novel Reservoir Targeted Antibiotic Against Borrelia burgdorferi$754,130
R01 · FY2023 · AI · contact PI
Role of human innate immune mutations in loss of tolerance to Borrelia burgdorferi$584,826
R01 · FY2023 · AI · contact PI
Auto-antibodies as predictive markers for Post treatment Lyme Disease Syndrome$555,172
R01 · FY2023 · AI · contact PI
Laboratory for Combinatorial Drug Regimen Design for Resistant and Emerging Pathogens$5,147,109
C06 · FY2022 · OD · contact PI
Development and Field Testing of a Novel Reservoir Targeted Antibiotic Against Borrelia burgdorferi$761,873
R01 · FY2022 · AI · contact PI
Role of human innate immune mutations in loss of tolerance to Borrelia burgdorferi$588,593
R01 · FY2022 · AI · contact PI
Development and Field Testing of a Novel Reservoir Targeted Antibiotic Against Borrelia burgdorferi$218,868
R01 · FY2022 · AI · contact PI
Development and Field Testing of a Novel Reservoir Targeted Antibiotic Against Borrelia burgdorferi$720,419
R01 · FY2021 · AI · contact PI
Coping with Stress: Next Generation Approaches to Borrelia burgdorferi Host Adaptation$661,519
R01 · FY2021 · AI · contact PI
Role of human innate immune mutations in loss of tolerance to Borrelia burgdorferi$590,473
R01 · FY2021 · AI · contact PI
Development and Field Testing of a Novel Reservoir Targeted Antibiotic Against Borrelia burgdorferi$743,299
R01 · FY2020 · AI · contact PI
Coping with Stress: Next Generation Approaches to Borrelia burgdorferi Host Adaptation$661,519
R01 · FY2020 · AI · contact PI
Role of human innate immune mutations in loss of tolerance to Borrelia burgdorferi$612,118
R01 · FY2020 · AI · contact PI
Understanding Human Immunological Responses to Ixodes Tick Bites$247,500
R21 · FY2020 · AI · contact PI
Coping with Stress: Next Generation Approaches to Borrelia burgdorferi Host Adaptation$661,519
R01 · FY2019 · AI · contact PI
Persister cells of Borrelia burgdorferi$572,380
R01 · FY2019 · AI
Understanding Human Immunological Responses to Ixodes Tick Bites$206,250
R21 · FY2019 · AI · contact PI
Searching for Persistence in Lyme Disease$797,360
U01 · FY2018 · AI · contact PI
Coping with Stress: Next Generation Approaches to Borrelia burgdorferi Host Adaptation$661,519
R01 · FY2018 · AI · contact PI
Physiological Interaction Between Probiotic Bacteria and Porphyromonas gingivalis$617,870
R01 · FY2018 · DE
Persister cells of Borrelia burgdorferi$572,380
R01 · FY2018 · AI
Infectious Disease Training-Pathogenesis/Host Response$188,863
T32 · FY2018 · AI · contact PI
Searching for Persistence in Lyme Disease$797,360
U01 · FY2017 · AI · contact PI
Coping with Stress: Next Generation Approaches to Borrelia burgdorferi Host Adaptation$675,327
R01 · FY2017 · AI · contact PI
Physiological Interaction Between Probiotic Bacteria and Porphyromonas gingivalis$616,813
R01 · FY2017 · DE
Persister cells of Borrelia burgdorferi$572,380
R01 · FY2017 · AI
Role of innate immune tolerance in the pathogenesis of Lyme disease$247,500
R21 · FY2017 · AI · contact PI
Infectious Disease Training-Pathogenesis/Host Response$222,182
T32 · FY2017 · AI · contact PI
Infectious Disease Training-Pathogenesis/Host Response$7,776
T32 · FY2017 · AI · contact PI
Searching for Persistence in Lyme Disease$797,360
U01 · FY2016 · AI · contact PI
Physiological Interaction Between Probiotic Bacteria and Porphyromonas gingivalis$621,833
R01 · FY2016 · DE
Persister cells of Borrelia burgdorferi$586,005
R01 · FY2016 · AI
Role of carbon availability in environmental adaptation by Borrelia burgdorferi$258,312
R21 · FY2016 · AI · contact PI
Infectious Disease Training-Pathogenesis/Host Response$235,304
T32 · FY2016 · AI · contact PI
Role of innate immune tolerance in the pathogenesis of Lyme disease$206,250
R21 · FY2016 · AI · contact PI
Searching for Persistence in Lyme Disease$813,610
U01 · FY2015 · AI · contact PI
Physiological Interaction Between Probiotic Bacteria and Porphyromonas gingivalis$627,813
R01 · FY2015 · DE
Infectious Disease Training-Pathogenesis/Host Response$282,008
T32 · FY2015 · AI · contact PI
Role of carbon availability in environmental adaptation by Borrelia burgdorferi$216,450
R21 · FY2015 · AI · contact PI
Delivery system development for a reservoir targeted Lyme disease vaccine$1,000,000
R42 · FY2014 · AI · contact PI
Searching for Persistence in Lyme Disease$817,356
U01 · FY2014 · AI · contact PI
Physiological Interaction Between Probiotic Bacteria and Porphyromonas gingivalis$657,950
R01 · FY2014 · DE
Infectious Disease Training-Pathogenesis/Host Response$256,944
T32 · FY2014 · AI · contact PI
Use of massively parallel sequencing for identification of B. burgdorferi virulen$234,650
R21 · FY2014 · AI · contact PI
Delivery system development for a reservoir targeted Lyme disease vaccine$1,000,000
R42 · FY2013 · AI · contact PI
Role of Endosomal Localization in Toll-like receptor 2 Responses to Borrelia$238,500
R21 · FY2013 · AI · contact PI
Use of massively parallel sequencing for identification of B. burgdorferi virulen$197,956
R21 · FY2013 · AI · contact PI
13th International Conference on Lyme Borreliosis and Other Tick-borne Diseases$8,000
R13 · FY2013 · AI · contact PI
Delivery system development for a reservoir targeted Lyme disease vaccine$1,000,000
R42 · FY2012 · AI · contact PI
Infectious Disease Training-pathogenesis/Host Response$294,130
T32 · FY2012 · AI · contact PI
Role of Endosomal Localization in Toll-like receptor 2 Responses to Borrelia$198,750
R21 · FY2012 · AI · contact PI
Xenodiagnosis of Lyme Disease$157,703
R21 · FY2012 · AI · contact PI
Infectious Disease Training-pathogenesis/Host Response$308,626
T32 · FY2011 · AI · contact PI
Role of Borrelia Integrin binding proteins in Lyme arthritis$357,750
R56 · FY2010 · AI · contact PI
Recognition of host catecholamines in Borrelia burgdorferi gene regulation$322,000
R01 · FY2010 · AI · contact PI
Development of a multivalent vaccine for mouse reservoirs of deer tick pathogens$310,829
R01 · FY2010 · AI · contact PI
Infectious Disease Training-pathogenesis/Host Response$300,264
T32 · FY2010 · AI · contact PI
Xenodiagnosis of Lyme Disease$241,027
R21 · FY2010 · AI · contact PI
Role of Borrelia Integrin binding proteins in Lyme arthritis$350,199
R56 · FY2009 · AI · contact PI
Recognition of host catecholamines in Borrelia burgdorferi gene regulation$322,000
R01 · FY2009 · AI · contact PI
Development of a multivalent vaccine for mouse reservoirs of deer tick pathogens$322,000
R01 · FY2009 · AI · contact PI
Delivery system development for a reservoir targeted Lyme disease vaccine$299,696
R41 · FY2009 · AI · contact PI
Xenodiagnosis of Lyme Disease$230,479
R21 · FY2009 · AI · contact PI
Delivery system development for a reservoir targeted Lyme disease vaccine$299,923
R41 · FY2008 · AI · contact PI
Bacterial immunomodulation in periodontitis$239,759
R21 · FY2008 · DE · contact PI
Bacterial immunomodulation in periodontitis$217,398
R21 · FY2007 · DE · contact PI
Pathogenesis of Borrelia burgdorferi induced arthritis$335,472
R01 · FY2006 · AI · contact PI
Development of a vaccine for murine Lyme disease$287,559
U01 · FY2006 · AI · contact PI
Pathogenesis of Borrelia burgdorferi induced arthritis$343,545
R01 · FY2005 · AI
Development of a vaccine for murine Lyme disease$306,624
U01 · FY2005 · AI
Pathogenesis of Borrelia burgdorferi induced arthritis$343,545
R01 · FY2004 · AI
PEPTIDE TRANSPORT AND SIGNALING IN BORRELIA BURGDORFERI$316,000
R01 · FY2004 · AI
Development of a vaccine for murine Lyme disease$205,850
U01 · FY2004 · AI
Pathogenesis of Borrelia burgdorferi induced arthritis$343,545
R01 · FY2003 · AI
PEPTIDE TRANSPORT AND SIGNALING IN BORRELIA BURGDORFERI$316,000
R01 · FY2003 · AI
Development of a vaccine for murine Lyme disease$107,124
U01 · FY2003 · AI
Pathogenesis of Borrelia burgdorferi induced arthritis$382,965
R01 · FY2002 · AI
PEPTIDE TRANSPORT AND SIGNALING IN BORRELIA BURGDORFERI$316,000
R01 · FY2002 · AI
PEPTIDE TRANSPORT AND SIGNALING IN BORRELIA BURGDORFERI$316,000
R01 · FY2001 · AI
PEPTIDE TRANSPORT AND SIGNALING IN BORRELIA BURGDORFERI$344,663
R01 · FY2000 · AI